WO2020103916A1 - Separation and purification method for uridine triphosphate - Google Patents

Separation and purification method for uridine triphosphate

Info

Publication number
WO2020103916A1
WO2020103916A1 PCT/CN2019/120049 CN2019120049W WO2020103916A1 WO 2020103916 A1 WO2020103916 A1 WO 2020103916A1 CN 2019120049 W CN2019120049 W CN 2019120049W WO 2020103916 A1 WO2020103916 A1 WO 2020103916A1
Authority
WO
WIPO (PCT)
Prior art keywords
separation
uridine triphosphate
purification
chromatography column
eluent
Prior art date
Application number
PCT/CN2019/120049
Other languages
French (fr)
Chinese (zh)
Inventor
江必旺
石凌超
邹胜
张彦辉
Original Assignee
苏州纳微科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 苏州纳微科技股份有限公司 filed Critical 苏州纳微科技股份有限公司
Publication of WO2020103916A1 publication Critical patent/WO2020103916A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification

Definitions

  • the invention relates to the technical field of drug purification, in particular to a method for separating and purifying uridine triphosphate.
  • Uridine triphosphate is a uracil nucleotide composed of a uracil, a ribose, and three phosphates, in which the phosphate group is attached to the 5 'carbon.
  • UTP is closely related to carbohydrate metabolism.
  • UTP and glucose 1-phosphate are catalyzed by enzymes to produce UDP-glucose and pyrophosphate.
  • UDP-galactose, UDP-galactosamine, UDP-glucuronic acid and the like are also produced.
  • UTP is involved in the synthesis of pyrimidine ribonucleotides and is the raw material for RNA synthesis (transcription).
  • UTP can also be used as an energy source, and its function is similar to ATP, but it is rarer than ATP.
  • UTP is also involved in many energy metabolism pathways in organisms.
  • UTP is also involved in the activation process of certain G protein-coupled receptors (such as P2Y, P2Y2, P2Y11, etc.), thereby activating epithelial chloride channels, increasing the frequency of ciliary swings, and inducing degranulation of goblet cells in respiratory epithelial cells , Can also affect the role of inflammatory cells and vascular reactivity.
  • G protein-coupled receptors such as P2Y, P2Y2, P2Y11, etc.
  • UTP is also commonly used in the diagnosis and treatment of certain diseases (such as INS316, lung cancer, etc.). It also plays an important role in sinusitis, chronic bronchitis, otitis media, dry eye and gastrointestinal diseases. Its market price can reach 12,000 yuan / kg, and it has broad application prospects in the pharmaceutical market.
  • GB1167288 discloses a method for purifying uridine triphosphate.
  • the invention provides an improved method for purifying UDP and / or UTP from its aqueous solution by using an ion exchange method, whereby a concentrated solution of UDP or UTP can be obtained.
  • This method uses a two-step ion exchange resin to separate UTP.
  • the purity of the sample after purification is 97% and the yield is 72.2%.
  • the purification effect is poor and the yield is relatively low.
  • the object of the present invention is to provide a method for separating and purifying uridine triphosphate. Only one step of chromatographic purification can meet the requirements of high purity of uridine triphosphate, and the purification yield is high and stable, and the purity Over 99%, the yield is 86.54 ⁇ 90.24.
  • the present invention adopts the following technical solutions:
  • a method for separating and purifying uridine triphosphate includes the following steps:
  • the separation and purification method of the present invention can meet the requirements of high purity of uridine triphosphate in only one step of chromatography purification.
  • the purification yield is high and stable, the purity is more than 99%, and the purification yield is high and stable.
  • the separation method of the present invention Simple and convenient, the purification cycle is short, and no organic solvent is used in the entire purification process, which can be used for large-scale production, which greatly reduces the production cost.
  • the monodisperse microspheres are microspheres with a monodisperse particle size and a pore structure.
  • the particle diameter of the monodisperse microspheres is 40-60 ⁇ m, for example, the particle diameter of the monodisperse microspheres is 40 ⁇ m, 41 ⁇ m, 42 ⁇ m, 43 ⁇ m, 44 ⁇ m, 45 ⁇ m, 46 ⁇ m, 47 ⁇ m, 48 ⁇ m, 49 ⁇ m , 50 ⁇ m, 51 ⁇ m, 52 ⁇ m, 53 ⁇ m, 54 ⁇ m, 55 ⁇ m, 56 ⁇ m, 57 ⁇ m, 58 ⁇ m, 59 ⁇ m, 60 ⁇ m; the pore size is For example, the aperture is
  • the model of the monodisperse microspheres is UniQ-50XS, produced by Suzhou Nanomicro Technology Co., Ltd., with a particle size of 55 ⁇ m and a pore size of
  • the chromatography medium UniQ-50XS used in the purification process is a monodisperse microsphere in which the matrix bonded to the quaternary amine group is polyacrylate.
  • the molecular formula of uridine triphosphate contains three phosphate groups.
  • UniQ-50XS produced by Suzhou Nanomicro Technology Co., Ltd. is used for UTP purification to obtain very good results.
  • the framework structure of the polyacrylate can tolerate the full pH range, and the column can be thoroughly cleaned at a high pH in the later stage, which is convenient for industrial repeated use, the filler has a long life, and reduces the cost.
  • the particle diameter of the monodisperse microspheres is 55 ⁇ m, and the pore diameter is
  • step 1) the HPLC purity of the crude uridine triphosphate is 64-66%, for example, the HPLC purity of the crude product is 64%, 64.1%, 64.2%, 64.3%, 64.4%, 64.5%, 64.6%, 64.7% , 64.8%, 64.9%, 65%, 65.1%, 65.2%, 65.23%, 65.3%, 65.417%, 65.5%, 65.6%, 65.7%, 65.8%, 65.9%, 66%.
  • the packing volume of the chromatography column is 4-20 mL, for example, the packing volume is 4.15 mL, 4.65 mL, 5 mL, 6 mL, 7 mL, 8 mL, 9 mL, 10 mL, 11 mL, 12 mL, 13 mL, 14 mL, 15mL, 15.5mL, 15.7mL, 16mL, 17mL, 18mL, 19mL, 20mL; loading capacity is 10-30g / L, for example loading capacity is 10g / L, 11g / L, 12g / L, 13g / L , 14g / L, 15g / L, 16g / L, 17g / L, 18g / L, 19g / L, 20g / L, 21g / L, 22g / L, 23g / L, 24g / L, 25g / L, 26g / L, 27g / L, 28g / L, 29g
  • the eluent contains 0.5 to 2 mol of salt solution
  • the mole number of the salt solution is 0.5 mol, 0.6 mol, 0.7 mol, 0.8 mol, 0.9 mol, 1 mol, 1.1 mol, 1.2 mol, 1.3 mol , 1.4mol, 1.5mol, 1.6mol, 1.7mol, 1.8mol, 1.9mol, 2mol, and does not contain organic solvents, safe, pollution-free and low cost.
  • the salt solution is one of sodium chloride, ammonium chloride and sodium acetate.
  • the flow rate of the eluent is 200-300 cm / h, for example, the flow rate of the eluent is 200 cm / h, 210 cm / h, 220 cm / h, 230 cm / h, 240 cm / h, 250 cm / h, 260cm / h, 270cm / h, 280cm / h, 290cm / h, 300cm / h.
  • the elution amount of the eluent is 60-80CV, for example, the elution amount of the eluent is 60CV, 61CV, 62CV, 63CV, 64CV, 65CV, 66CV, 67CV, 68CV, 69CV, 70CV, 71CV, 72CV, 73CV, 74CV, 75CV, 76CV, 77CV, 78CV, 79CV, 80CV.
  • the separation and purification method of uridine triphosphate includes the following steps:
  • the separation and purification method of uridine triphosphate of the present invention can meet the requirements of high purity of uridine triphosphate in only one step of chromatographic purification.
  • the purification yield is high and stable, with a purity of more than 99% and a yield of 86.54 ⁇ 90.24%.
  • the separation and purification method of uridine triphosphate of the present invention is simple and convenient, and the purification cycle is short, and only the salt solution is used as the mobile phase in the entire purification process, without using any organic solvent, safe, non-polluting, and low cost,
  • the used stationary phase can be reused and can be used for large-scale production, which greatly reduces environmental protection pressure and production costs.
  • Example 1 is a scanning electron micrograph of UniQ-50XS polyacrylate microspheres used in Example 1 of the method for separating and purifying uridine triphosphate of the present invention
  • Example 2 is a high performance liquid chromatogram of the purified crude uridine triphosphate of Example 1 of the present invention
  • Example 3 is a high performance liquid chromatogram of uridine triphosphate after purification in Example 1 of the present invention.
  • the method for separating and purifying uridine triphosphate of the present invention includes the following steps:
  • the chromatographic column is equilibrated before loading, and then loaded, and then eluted by gradient elution.
  • the solution of the target peak is collected in stages, and the component solutions that meet the requirements are summarized.
  • the purity of uridine triphosphate in the eluent is 99.05%, and the yield is 90.20%.
  • Figure 1 is a scanning electron micrograph of UniQ-50XS strong anion exchange resin microspheres. As can be seen from Figure 1, the microspheres exhibit a high degree of particle size uniformity.
  • Figure 2 is a high-performance liquid chromatogram of crude uridine triphosphate before purification. As can be seen from Figure 2, the crude uridine triphosphate has high impurity content, which does not meet the high purity requirements of uridine triphosphate.
  • Figure 3 is a high-performance liquid chromatogram of uridine triphosphate after purification. As can be seen from Figure 3, the impurity content in uridine triphosphate after purification is reduced, which meets the high purity requirements of uridine triphosphate.
  • the chromatographic column is equilibrated before loading, and then loaded, and then eluted by gradient elution.
  • the chromatographic column is equilibrated before loading, and then loaded, and then eluted by gradient elution.
  • the chromatographic column is equilibrated before loading, and then loaded, and then eluted by gradient elution.
  • the separation and purification method of uridine triphosphate of the present invention can meet the requirements of high purity of uridine triphosphate in only one step of chromatography purification, and the purification yield is high and stable, with a purity of more than 99% and a yield of 86.54 ⁇ 90.24%.
  • the separation and purification method of uridine triphosphate of the present invention is simple and convenient, and the purification cycle is short, and only the salt solution is used as the mobile phase in the entire purification process, without using any organic solvent, which is safe, non-polluting, and low in cost.
  • the stationary phase can be reused and can be used for large-scale production, which greatly reduces environmental protection pressure and production costs.
  • the present invention illustrates the detailed process equipment and process flow of the present invention through the above embodiments, but the present invention is not limited to the above detailed process equipment and process flow, that does not mean that the present invention must be dependent on the above detailed process equipment and process flow to implement .
  • Those skilled in the art should understand that any improvement to the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, choice of specific methods, etc., fall within the scope of protection and disclosure of the present invention.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Provided is a separation and purification method for uridine triphosphate. The separation and purification method comprises the following steps: 1) loading: filtering crude uridine triphosphate and then loading same into a chromatography column, wherein the packing of the chromatography column is monodisperse microspheres with polyacrylate as a matrix; 2) eluting: eluting UTP adsorbed in the chromatography column with an eluate; and 3) collecting and gathering: collecting the eluted uridine triphosphate solution in sections, and gathering component solutions that meet the target peak requirements. The separation and purification method for uridine triphosphate of the present invention is simple and convenient, has a short purification cycle, and can satisfy the high purity requirement of uridine triphosphate by means of only one step of chromatography purification. The uridine triphosphate has a purity of 99.9% or more and a high and stable purification yield.

Description

一种尿苷三磷酸的分离纯化方法Method for separating and purifying uridine triphosphate 技术领域Technical field
本发明涉及药物纯化技术领域,具体涉及一种尿苷三磷酸的分离纯化方法。The invention relates to the technical field of drug purification, in particular to a method for separating and purifying uridine triphosphate.
背景技术Background technique
尿苷三磷酸(Uridine triphosphate,简称UTP)是一种尿嘧啶核苷酸,由一个尿嘧啶、一个核糖、三个磷酸连接而成,其中,磷酸基团连于5’碳上。UTP与糖类代谢有密切关系,由UTP与1-磷酸葡糖经酶催化生成UDP-葡糖与焦磷酸。另外,也生成UDP-半乳糖、UDP-半乳糖胺、UDP-萄糖醛酸等。Uridine triphosphate (UTP) is a uracil nucleotide composed of a uracil, a ribose, and three phosphates, in which the phosphate group is attached to the 5 'carbon. UTP is closely related to carbohydrate metabolism. UTP and glucose 1-phosphate are catalyzed by enzymes to produce UDP-glucose and pyrophosphate. In addition, UDP-galactose, UDP-galactosamine, UDP-glucuronic acid and the like are also produced.
UTP参与嘧啶核糖核苷酸的合成,是RNA合成(转录)时的原料,另外,UTP也可用作能量来源,功能类似ATP,但较ATP少见。在有机体的很多能量代谢途径中,也有UTP的参与。UTP is involved in the synthesis of pyrimidine ribonucleotides and is the raw material for RNA synthesis (transcription). In addition, UTP can also be used as an energy source, and its function is similar to ATP, but it is rarer than ATP. UTP is also involved in many energy metabolism pathways in organisms.
UTP还参与某些G蛋白偶联受体(例如P2Y、P2Y2、P2Y11等)的活化过程,从而激活上皮细胞氯离子通道,增加纤毛的摆动频率,诱导呼吸道上皮细胞中的杯状细胞脱颗粒作用,也能影响炎症细胞作用和血管反应度。另外,UTP也常应用于某些疾病(例如INS316、肺癌等)的诊断和治疗。其在鼻窦炎、慢性支气管炎、中耳炎、干眼症及胃肠道疾病方面也起着较重要的作用,其市场价格可以达到12000元/kg,在药物市场上有广阔的应用前景。UTP is also involved in the activation process of certain G protein-coupled receptors (such as P2Y, P2Y2, P2Y11, etc.), thereby activating epithelial chloride channels, increasing the frequency of ciliary swings, and inducing degranulation of goblet cells in respiratory epithelial cells , Can also affect the role of inflammatory cells and vascular reactivity. In addition, UTP is also commonly used in the diagnosis and treatment of certain diseases (such as INS316, lung cancer, etc.). It also plays an important role in sinusitis, chronic bronchitis, otitis media, dry eye and gastrointestinal diseases. Its market price can reach 12,000 yuan / kg, and it has broad application prospects in the pharmaceutical market.
其中,尿苷三磷酸的结构式如下:Among them, the structural formula of uridine triphosphate is as follows:
Figure PCTCN2019120049-appb-000001
Figure PCTCN2019120049-appb-000001
UTP的主要合成工艺是利用微生物细胞酶系合成,目前,国内外专利、文献等鲜有公开对尿苷三磷酸纯化工艺的报道。The main synthesis process of UTP is to use microbial cell enzyme system synthesis. At present, there are few reports on the purification process of uridine triphosphate in domestic and foreign patents and documents.
GB1167288公开了一种尿苷三磷酸的纯化方法,该发明提供了一种通过使用离子交换方法从其水溶液中纯化UDP和/或UTP的改进方法,由此可以获得UDP或UTP的浓缩溶液。该方法使用两步离子交换树脂分离UTP,纯化后样品纯度为97%,收率72.2%,纯化效果较差,收率也相对较低。GB1167288 discloses a method for purifying uridine triphosphate. The invention provides an improved method for purifying UDP and / or UTP from its aqueous solution by using an ion exchange method, whereby a concentrated solution of UDP or UTP can be obtained. This method uses a two-step ion exchange resin to separate UTP. The purity of the sample after purification is 97% and the yield is 72.2%. The purification effect is poor and the yield is relatively low.
肖明芳等在其硕士论文《离子交换法分离纯化5,-尿苷三磷酸》中使用离子交换法纯化了尿苷三磷酸,纯化后样品纯度为97.17%,收率92.25%,纯化工艺中使用的树脂为实验室自行合成的,难以实现稳定性和产业化。Xiao Mingfang et al. Used ion exchange to purify uridine triphosphate in their master thesis "Ion Exchange Separation and Purification of 5, Uridine Triphosphate". After purification, the purity of the sample was 97.17%, the yield was 92.25%, and it was used in the purification process The resin is synthesized by the laboratory itself, and it is difficult to achieve stability and industrialization.
因此,为了得到高纯度、高收率的尿苷三磷酸且纯化周期短、稳定性高的分离纯化工艺,有必要对尿苷三磷酸的精细纯化工艺做更进一步的研究。Therefore, in order to obtain a high-purity, high-yield uridine triphosphate with a short purification cycle and high stability, it is necessary to further study the fine purification process of uridine triphosphate.
发明内容Summary of the invention
针对现有技术的不足,本发明的目的在于提供一种尿苷三磷酸的分离纯化方法,仅需一步层析纯化即可满足尿苷三磷酸高纯度的要求,纯化收率高而且稳定,纯度达99%以上,收率为86.54~90.24。In view of the shortcomings of the prior art, the object of the present invention is to provide a method for separating and purifying uridine triphosphate. Only one step of chromatographic purification can meet the requirements of high purity of uridine triphosphate, and the purification yield is high and stable, and the purity Over 99%, the yield is 86.54 ~ 90.24.
为达此目的,本发明采用以下技术方案:To achieve this goal, the present invention adopts the following technical solutions:
一种尿苷三磷酸的分离纯化方法,所述分离纯化方法包括如下步骤:A method for separating and purifying uridine triphosphate. The method includes the following steps:
1)上样:将尿苷三磷酸粗品过滤后上样到层析柱中,所述层析柱填料是基质为聚丙烯酸酯的单分散微球;1) Loading: The crude uridine triphosphate is filtered and loaded into a chromatography column, and the packing material of the chromatography column is monodisperse microspheres with a matrix of polyacrylate;
2)洗脱:对吸附在层析柱中的UTP用洗脱液进行洗脱;2) Elution: elute the UTP adsorbed in the chromatography column with the eluent;
3)收集汇总:对洗脱后的尿苷三磷酸溶液进行分段收集,对符合目的峰值要求的组份液进行汇总。3) Collection and collection: The eluted uridine triphosphate solution is collected in stages, and the component liquids that meet the target peak requirements are collected.
本发明的分离纯化方法,仅需一步层析纯化即可满足尿苷三磷酸高纯度的要求,纯化收率高而稳定,纯度达99%以上,纯化收率高而且稳定,同时本发明分离方法简单方便,纯化周期短,且整个纯化过程中无需使用任何有机溶剂,可用于规模化生产,大大降低了生产成本。The separation and purification method of the present invention can meet the requirements of high purity of uridine triphosphate in only one step of chromatography purification. The purification yield is high and stable, the purity is more than 99%, and the purification yield is high and stable. At the same time, the separation method of the present invention Simple and convenient, the purification cycle is short, and no organic solvent is used in the entire purification process, which can be used for large-scale production, which greatly reduces the production cost.
步骤1)中,所述单分散微球为粒径呈单分散的、具有孔道结构的微球。In step 1), the monodisperse microspheres are microspheres with a monodisperse particle size and a pore structure.
优选地,步骤1)中,所述单分散微球的粒径为40~60μm,例如单分散微球的粒径为40μm、41μm、42μm、43μm、44μm、45μm、46μm、47μm、48μm、49μm、50μm、51μm、52μm、53μm、54μm、55μm、56μm、57μm、58μm、59μm、60μm;孔径为
Figure PCTCN2019120049-appb-000002
例如孔径为
Figure PCTCN2019120049-appb-000003
Figure PCTCN2019120049-appb-000004
Preferably, in step 1), the particle diameter of the monodisperse microspheres is 40-60 μm, for example, the particle diameter of the monodisperse microspheres is 40 μm, 41 μm, 42 μm, 43 μm, 44 μm, 45 μm, 46 μm, 47 μm, 48 μm, 49 μm , 50μm, 51μm, 52μm, 53μm, 54μm, 55μm, 56μm, 57μm, 58μm, 59μm, 60μm; the pore size is
Figure PCTCN2019120049-appb-000002
For example, the aperture is
Figure PCTCN2019120049-appb-000003
Figure PCTCN2019120049-appb-000004
优选地,步骤1)中,所述单分散微球的型号为UniQ-50XS,苏州纳微科技股份有限公司生产的,粒径为55μm,孔径为
Figure PCTCN2019120049-appb-000005
Preferably, in step 1), the model of the monodisperse microspheres is UniQ-50XS, produced by Suzhou Nanomicro Technology Co., Ltd., with a particle size of 55 μm and a pore size of
Figure PCTCN2019120049-appb-000005
本发明中,纯化过程中所使用的层析介质UniQ-50XS,是键合季胺基的基质为聚丙烯酸酯的单分散微球。尿苷三磷酸分子式中含有三个磷酸根,优选地,在选定的洗脱条件下,使用苏州纳微科技股份有限公司生产的UniQ-50XS用于 UTP纯化取到了非常好的效果。同时,聚丙烯酸酯的骨架结构可耐受全pH范围,并可在后期对层析柱进行高pH下的彻底清洗,便于工业上的反复利用,填料寿命长,降低了成本。In the present invention, the chromatography medium UniQ-50XS used in the purification process is a monodisperse microsphere in which the matrix bonded to the quaternary amine group is polyacrylate. The molecular formula of uridine triphosphate contains three phosphate groups. Preferably, under the selected elution conditions, UniQ-50XS produced by Suzhou Nanomicro Technology Co., Ltd. is used for UTP purification to obtain very good results. At the same time, the framework structure of the polyacrylate can tolerate the full pH range, and the column can be thoroughly cleaned at a high pH in the later stage, which is convenient for industrial repeated use, the filler has a long life, and reduces the cost.
更优选地,步骤1)中,所述单分散微球的粒径为55μm,孔径为
Figure PCTCN2019120049-appb-000006
More preferably, in step 1), the particle diameter of the monodisperse microspheres is 55 μm, and the pore diameter is
Figure PCTCN2019120049-appb-000006
步骤1)中,所述尿苷三磷酸粗品的HPLC纯度为64~66%,例如粗品的HPLC纯度为64%、64.1%、64.2%、64.3%、64.4%、64.5%、64.6%、64.7%、64.8%、64.9%、65%、65.1%、65.2%、65.23%、65.3%、65.417%、65.5%、65.6%、65.7%、65.8%、65.9%、66%。In step 1), the HPLC purity of the crude uridine triphosphate is 64-66%, for example, the HPLC purity of the crude product is 64%, 64.1%, 64.2%, 64.3%, 64.4%, 64.5%, 64.6%, 64.7% , 64.8%, 64.9%, 65%, 65.1%, 65.2%, 65.23%, 65.3%, 65.417%, 65.5%, 65.6%, 65.7%, 65.8%, 65.9%, 66%.
步骤1)中,所述层析柱的装柱体积为4~20mL,例如装柱体积为4.15mL、4.65mL、5mL、6mL、7mL、8mL、9mL、10mL、11mL、12mL、13mL、14mL、15mL、15.5mL、15.7mL、16mL、17mL、18mL、19mL、20mL;上样载量为10-30g/L,例如上样载量为10g/L、11g/L、12g/L、13g/L、14g/L、15g/L、16g/L、17g/L、18g/L、19g/L、20g/L、21g/L、22g/L、23g/L、24g/L、25g/L、26g/L、27g/L、28g/L、29g/L、30g/L。In step 1), the packing volume of the chromatography column is 4-20 mL, for example, the packing volume is 4.15 mL, 4.65 mL, 5 mL, 6 mL, 7 mL, 8 mL, 9 mL, 10 mL, 11 mL, 12 mL, 13 mL, 14 mL, 15mL, 15.5mL, 15.7mL, 16mL, 17mL, 18mL, 19mL, 20mL; loading capacity is 10-30g / L, for example loading capacity is 10g / L, 11g / L, 12g / L, 13g / L , 14g / L, 15g / L, 16g / L, 17g / L, 18g / L, 19g / L, 20g / L, 21g / L, 22g / L, 23g / L, 24g / L, 25g / L, 26g / L, 27g / L, 28g / L, 29g / L, 30g / L.
步骤2)中,所述洗脱液含0.5~2mol的盐溶液,例如盐溶液的摩尔数为0.5mol、0.6mol、0.7mol、0.8mol、0.9mol、1mol、1.1mol、1.2mol、1.3mol、1.4mol、1.5mol、1.6mol、1.7mol、1.8mol、1.9mol、2mol,且不含有机溶剂,安全、无污染且成本很低。In step 2), the eluent contains 0.5 to 2 mol of salt solution, for example, the mole number of the salt solution is 0.5 mol, 0.6 mol, 0.7 mol, 0.8 mol, 0.9 mol, 1 mol, 1.1 mol, 1.2 mol, 1.3 mol , 1.4mol, 1.5mol, 1.6mol, 1.7mol, 1.8mol, 1.9mol, 2mol, and does not contain organic solvents, safe, pollution-free and low cost.
优选地,所述盐溶液为氯化钠、氯化铵和乙酸钠中的一种。Preferably, the salt solution is one of sodium chloride, ammonium chloride and sodium acetate.
步骤2)中,所述洗脱液的流速为200~300cm/h,例如洗脱液的流速为200cm/h、210cm/h、220cm/h、230cm/h、240cm/h、250cm/h、260cm/h、270cm/h、280cm/h、290cm/h、300cm/h。In step 2), the flow rate of the eluent is 200-300 cm / h, for example, the flow rate of the eluent is 200 cm / h, 210 cm / h, 220 cm / h, 230 cm / h, 240 cm / h, 250 cm / h, 260cm / h, 270cm / h, 280cm / h, 290cm / h, 300cm / h.
步骤2)中,所述洗脱液的洗脱量为60~80CV,例如所述洗脱液的洗脱量为60CV、61CV、62CV、63CV、64CV、65CV、66CV、67CV、68CV、69CV、70CV、71CV、72CV、73CV、74CV、75CV、76CV、77CV、78CV、79CV、80CV。In step 2), the elution amount of the eluent is 60-80CV, for example, the elution amount of the eluent is 60CV, 61CV, 62CV, 63CV, 64CV, 65CV, 66CV, 67CV, 68CV, 69CV, 70CV, 71CV, 72CV, 73CV, 74CV, 75CV, 76CV, 77CV, 78CV, 79CV, 80CV.
作为本发明的优选方案,尿苷三磷酸的分离纯化方法,包括如下步骤:As a preferred solution of the present invention, the separation and purification method of uridine triphosphate includes the following steps:
1)上样:将纯度为64~66%的尿苷三磷酸粗品过滤后上样到层析柱中,其中,所述层析柱的装柱体积为4~20mL,上样载量为10~30g/L,所述层析柱填料是基质为聚丙烯酸酯的单分散微球UniQ-50XS;1) Sample loading: The crude uridine triphosphate with a purity of 64-66% is filtered and loaded onto a chromatography column, wherein the column packing volume of the chromatography column is 4-20 mL, and the sample loading capacity is 10 ~ 30g / L, the chromatography column packing is a monodisperse microsphere UniQ-50XS whose matrix is polyacrylate;
2)洗脱:对吸附在层析柱中的UTP用洗脱液进行洗脱,其中,所述洗脱液含0.5~2mol的盐溶液,且不含有机溶剂,所述洗脱液的流速为200~300cm/h,所述洗脱液的洗脱量为60~80CV;2) Elution: The UTP adsorbed in the chromatography column is eluted with an eluent, wherein the eluent contains 0.5 to 2 mol of salt solution and contains no organic solvent, and the flow rate of the eluent 200-300cm / h, the elution amount of the eluent is 60-80CV;
3)收集汇总:对洗脱后的尿苷三磷酸溶液进行分段收集,对符合目的峰值要求的组份液进行汇总。3) Collection and collection: The eluted uridine triphosphate solution is collected in stages, and the component liquids that meet the target peak requirements are collected.
与现有技术相比,本发明的有益效果为:Compared with the prior art, the beneficial effects of the present invention are:
(1)本发明的尿苷三磷酸的分离纯化方法,仅需一步层析纯化即可满足尿苷三磷酸高纯度的要求,纯化收率高而且稳定,纯度达99%以上,收率为86.54~90.24%。(1) The separation and purification method of uridine triphosphate of the present invention can meet the requirements of high purity of uridine triphosphate in only one step of chromatographic purification. The purification yield is high and stable, with a purity of more than 99% and a yield of 86.54 ~ 90.24%.
(2)本发明的尿苷三磷酸的分离纯化方法,简单方便,纯化周期短,且整个纯化过程中仅用盐溶液作为流动相,无需使用任何有机溶剂,安全、无污染且成本很低,所用固定相可重复利用,可用于规模化生产,大大降低了环保压力和生产成本。(2) The separation and purification method of uridine triphosphate of the present invention is simple and convenient, and the purification cycle is short, and only the salt solution is used as the mobile phase in the entire purification process, without using any organic solvent, safe, non-polluting, and low cost, The used stationary phase can be reused and can be used for large-scale production, which greatly reduces environmental protection pressure and production costs.
附图说明BRIEF DESCRIPTION
图1为本发明尿苷三磷酸的分离纯化方法的实施例1使用的UniQ-50XS聚丙烯酸酯微球的扫描电镜图;1 is a scanning electron micrograph of UniQ-50XS polyacrylate microspheres used in Example 1 of the method for separating and purifying uridine triphosphate of the present invention;
图2为本发明的实施例1提纯前尿苷三磷酸粗品的高效液相色谱图;2 is a high performance liquid chromatogram of the purified crude uridine triphosphate of Example 1 of the present invention;
图3为本发明的实施例1纯化后尿苷三磷酸的高效液相色谱图。3 is a high performance liquid chromatogram of uridine triphosphate after purification in Example 1 of the present invention.
具体实施方式detailed description
下面结合附图1-3,并通过具体实施例对发明的技术方案作进一步的描述,但本发明并不限于这些实施例。The technical solutions of the invention will be further described below with reference to the accompanying drawings 1-3, and specific embodiments, but the invention is not limited to these embodiments.
本发明的一种尿苷三磷酸的分离纯化方法,包括如下步骤:The method for separating and purifying uridine triphosphate of the present invention includes the following steps:
1)上样:将尿苷三磷酸粗品过滤后上样到层析柱中,所述层析柱填料是基质为聚丙烯酸酯的单分散微球;1) Loading: The crude uridine triphosphate is filtered and loaded into a chromatography column, and the packing material of the chromatography column is monodisperse microspheres with a matrix of polyacrylate;
2)洗脱:对吸附在层析柱中的UTP用洗脱液进行洗脱;2) Elution: elute the UTP adsorbed in the chromatography column with the eluent;
3)收集汇总:对洗脱后的尿苷三磷酸溶液进行分段收集,对符合目的峰值要求的组份液进行汇总。3) Collection and collection: The eluted uridine triphosphate solution is collected in stages, and the component liquids that meet the target peak requirements are collected.
实施例1Example 1
取尿苷三磷酸粗品47.5mL(65.417%纯度,样品以流动相A稀释5倍),用孔径为0.45μm滤膜过滤,收集滤液待用。采用7.7×100mm的预装柱,UniQ-50XS强阴离子交换微球(苏州纳微科技股份有限公司生产)作为层析柱填料,装柱体积为4.65mL,上样载量20g/L。Take 47.5 mL of crude uridine triphosphate (65.417% purity, the sample is diluted 5 times with mobile phase A), filter with a 0.45 μm filter membrane, and collect the filtrate for use. A pre-packed column of 7.7 × 100mm was used. UniQ-50XS strong anion exchange microspheres (produced by Suzhou Nanomicro Technology Co., Ltd.) were used as the packing material for the chromatography column. The packed volume was 4.65mL, and the loading capacity was 20g / L.
上样前对层析柱进行平衡,而后上样,然后采用梯度洗脱方式进行洗脱。The chromatographic column is equilibrated before loading, and then loaded, and then eluted by gradient elution.
分段收集目的峰值的溶液,对符合要求的组份液进行汇总,经高效液相色谱分析,洗脱液中尿苷三磷酸的纯度99.05%,收率90.20%。The solution of the target peak is collected in stages, and the component solutions that meet the requirements are summarized. After high performance liquid chromatography analysis, the purity of uridine triphosphate in the eluent is 99.05%, and the yield is 90.20%.
图1是UniQ-50XS强阴离子交换树脂微球的扫描电镜图,由图1可以看出,微球呈现高度的粒径均一性。Figure 1 is a scanning electron micrograph of UniQ-50XS strong anion exchange resin microspheres. As can be seen from Figure 1, the microspheres exhibit a high degree of particle size uniformity.
图2是提纯前的尿苷三磷酸粗品的高效液相色谱图,由图2可以看出,尿苷三磷酸粗品中杂质含量高,不符合尿苷三磷酸高纯度的要求。Figure 2 is a high-performance liquid chromatogram of crude uridine triphosphate before purification. As can be seen from Figure 2, the crude uridine triphosphate has high impurity content, which does not meet the high purity requirements of uridine triphosphate.
图3是提纯后的尿苷三磷酸高效液相色谱图,由图3可以看出,经纯化后尿苷三磷酸中的杂质含量降低,符合尿苷三磷酸高纯度的要求。Figure 3 is a high-performance liquid chromatogram of uridine triphosphate after purification. As can be seen from Figure 3, the impurity content in uridine triphosphate after purification is reduced, which meets the high purity requirements of uridine triphosphate.
实施例2Example 2
取尿苷三磷酸粗品320mL(65.23%纯度,样品以流动相A稀释5倍),用孔径为0.45μm滤膜过滤,收集滤液待用。采用Tricorn10-200色谱柱,UniQ-50XS强阴离子交换微球(苏州纳微科技股份有限公司生产)作为层析柱填料,装柱体积为15.7mL,上样载量20g/L。Take 320 mL of crude uridine triphosphate (65.23% purity, the sample is diluted 5 times with mobile phase A), filter with a 0.45 μm filter membrane, and collect the filtrate for use. A Tricorn 10-200 chromatographic column and UniQ-50XS strong anion exchange microspheres (manufactured by Suzhou Nanomicro Technology Co., Ltd.) were used as the packing material for the chromatographic column. The packed volume was 15.7 mL, and the loading capacity was 20 g / L.
上样前对层析柱进行平衡,而后上样,然后采用梯度洗脱方式进行洗脱。The chromatographic column is equilibrated before loading, and then loaded, and then eluted by gradient elution.
分段收集目的峰值的溶液,对符合要求的组份液进行汇总,经高效液相色谱分析,洗脱液中尿苷三磷酸的纯度99.089%,收率90.24%。Collect the solution of the target peak in stages, summarize the components that meet the requirements, and analyze by high performance liquid chromatography. The purity of uridine triphosphate in the eluent is 99.089%, and the yield is 90.24%.
实施例3Example 3
取尿苷三磷酸粗品45mL(63.947%纯度,样品以流动相A稀释5倍),用孔径为0.45μm滤膜过滤,收集滤液待用。采用7.7×100mm的预装柱,UniQ-50XS强阴离子交换微球(苏州纳微科技股份有限公司生产)作为层析柱填料,装柱体积为4.65mL,上样载量18g/L。Take 45mL of crude uridine triphosphate (63.947% purity, the sample is diluted 5 times with mobile phase A), filter with a 0.45μm filter membrane, and collect the filtrate for use. A pre-packed column of 7.7 × 100mm was used. UniQ-50XS strong anion exchange microspheres (manufactured by Suzhou Nano Micro Technology Co., Ltd.) were used as the packing material for the chromatography column. The packed column volume was 4.65mL and the loading capacity was 18g / L.
上样前对层析柱进行平衡,而后上样,然后采用梯度洗脱方式进行洗脱。The chromatographic column is equilibrated before loading, and then loaded, and then eluted by gradient elution.
分段收集目的峰值的溶液,对符合要求的组份液进行汇总,经高效液相色谱分析,洗脱液中尿苷三磷酸的纯度为99.408%,收率86.54%。The solution of the target peak was collected in stages, and the component liquids meeting the requirements were summarized. After high performance liquid chromatography analysis, the purity of uridine triphosphate in the eluent was 99.408%, and the yield was 86.54%.
实施例4Example 4
本实施例使用了另一种强阴离子交换微球UniQ-30S(苏州纳微科技股份有限公司生产)作为层析柱填料,其他纯化条件不变,与实施例1相同。In this example, another strong anion exchange microsphere UniQ-30S (manufactured by Suzhou Nano Micro Technology Co., Ltd.) was used as a chromatography column packing, and other purification conditions were unchanged, as in Example 1.
取尿苷三磷酸粗品47.5mL(65.417%纯度,样品以流动相A稀释5倍),用孔径为0.45μm滤膜过滤,收集滤液待用。采用7.7×100mm的预装柱,UniQ-30S强阴离子交换微球(粒径约36μm,孔径约
Figure PCTCN2019120049-appb-000007
)作为层析柱填料,装柱体积为4.65mL,上样载量20g/L。
Take 47.5 mL of crude uridine triphosphate (65.417% purity, the sample is diluted 5 times with mobile phase A), filter with a 0.45 μm filter membrane, and collect the filtrate for use. Using pre-packed columns of 7.7 × 100mm, UniQ-30S strong anion exchange microspheres (particle size about 36μm, pore size about
Figure PCTCN2019120049-appb-000007
) As the packing material of the chromatography column, the packing volume is 4.65mL, and the loading capacity is 20g / L.
上样前对层析柱进行平衡,而后上样,然后采用梯度洗脱方式进行洗脱。The chromatographic column is equilibrated before loading, and then loaded, and then eluted by gradient elution.
分段收集目的峰值的溶液,对符合要求的组份液进行汇总,经高效液相色谱分析。纯化后样品UTP的纯度为98.9%,收率85.2%。Collect the peak solution of interest in stages, summarize the components that meet the requirements, and analyze them by high performance liquid chromatography. The purity of the sample UTP after purification was 98.9%, and the yield was 85.2%.
综上,本发明的尿苷三磷酸的分离纯化方法,仅需一步层析纯化即可满足尿苷三磷酸高纯度的要求,纯化收率高而且稳定,纯度达99%以上,收率为86.54~90.24%。In summary, the separation and purification method of uridine triphosphate of the present invention can meet the requirements of high purity of uridine triphosphate in only one step of chromatography purification, and the purification yield is high and stable, with a purity of more than 99% and a yield of 86.54 ~ 90.24%.
另外,本发明的尿苷三磷酸的分离纯化方法,简单方便,纯化周期短,且整个纯化过程中仅用盐溶液作为流动相,无需使用任何有机溶剂,安全、无污染且成本很低,所用固定相可重复利用,可用于规模化生产,大大降低了环保压力和生产成本。In addition, the separation and purification method of uridine triphosphate of the present invention is simple and convenient, and the purification cycle is short, and only the salt solution is used as the mobile phase in the entire purification process, without using any organic solvent, which is safe, non-polluting, and low in cost. The stationary phase can be reused and can be used for large-scale production, which greatly reduces environmental protection pressure and production costs.
本发明通过上述实施例来说明本发明的详细工艺设备和工艺流程,但本发明并不局限于上述详细工艺设备和工艺流程,即不意味着本发明必须依赖上述详细工艺设备和工艺流程才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明产品各原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。The present invention illustrates the detailed process equipment and process flow of the present invention through the above embodiments, but the present invention is not limited to the above detailed process equipment and process flow, that does not mean that the present invention must be dependent on the above detailed process equipment and process flow to implement . Those skilled in the art should understand that any improvement to the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, choice of specific methods, etc., fall within the scope of protection and disclosure of the present invention.

Claims (10)

  1. 一种尿苷三磷酸的分离纯化方法,其特征在于,所述分离纯化方法包括如下步骤:A method for separating and purifying uridine triphosphate, characterized in that the method for separating and purifying comprises the following steps:
    1)上样:将尿苷三磷酸粗品过滤后上样到层析柱中,所述层析柱填料是基质为聚丙烯酸酯的单分散微球;1) Loading: The crude uridine triphosphate is filtered and loaded into a chromatography column, and the packing material of the chromatography column is monodisperse microspheres with a matrix of polyacrylate;
    2)洗脱:对吸附在层析柱中的UTP用洗脱液进行洗脱;2) Elution: elute the UTP adsorbed in the chromatography column with the eluent;
    3)收集汇总:对洗脱后的尿苷三磷酸溶液进行分段收集,对符合目的峰值要求的组份液进行汇总。3) Collection and collection: The eluted uridine triphosphate solution is collected in stages, and the component liquids that meet the target peak requirements are collected.
  2. 根据权利要求1所述的分离纯化方法,其特征在于,步骤1)中,所述单分散微球为粒径呈单分散的、具有孔道结构的微球。The method for separation and purification according to claim 1, wherein in step 1), the monodisperse microspheres are microspheres with a monodisperse particle size and a pore structure.
  3. 根据权利要求1或2所述的分离纯化方法,其特征在于,步骤1)中,所述单分散微球的粒径为40~60μm,孔径为
    Figure PCTCN2019120049-appb-100001
    The separation and purification method according to claim 1 or 2, wherein in step 1), the particle size of the monodisperse microspheres is 40-60 μm, and the pore size is
    Figure PCTCN2019120049-appb-100001
  4. 根据权利要求1-3之一所述的分离纯化方法,其特征在于,步骤1)中,所述单分散微球的型号为UniQ-50XS。The separation and purification method according to any one of claims 1 to 3, wherein in step 1), the model of the monodisperse microsphere is UniQ-50XS.
  5. 根据权利要求1-4之一所述的分离纯化方法,其特征在于,步骤1)中,所述尿苷三磷酸粗品的HPLC纯度为64~66%。The method for separation and purification according to any one of claims 1 to 4, wherein in step 1), the HPLC purity of the crude uridine triphosphate is 64 to 66%.
  6. 根据权利要求1-5之一所述的分离纯化方法,其特征在于,步骤1)中,所述层析柱的装柱体积为4~20mL,上样载量为10~30g/L。The separation and purification method according to any one of claims 1 to 5, wherein in step 1), the packed volume of the chromatography column is 4 to 20 mL, and the loading capacity of the sample is 10 to 30 g / L.
  7. 根据权利要求1-6之一所述的分离纯化方法,其特征在于,步骤2)中,所述洗脱液含0.5~2mol的盐溶液,且不含有机溶剂;The method for separation and purification according to any one of claims 1 to 6, characterized in that, in step 2), the eluent contains 0.5 to 2 mol of salt solution and no organic solvent;
    优选地,所述盐溶液为氯化钠、氯化铵和乙酸钠中的一种。Preferably, the salt solution is one of sodium chloride, ammonium chloride and sodium acetate.
  8. 根据权利要求1-7之一所述的分离纯化方法,其特征在于,步骤2)中,所述洗脱液的流速为200~300cm/h。The separation and purification method according to any one of claims 1-7, wherein in step 2), the flow rate of the eluent is 200-300 cm / h.
  9. 根据权利要求1-8之一所述的分离纯化方法,其特征在于,步骤2)中,所述洗脱液的洗脱量为60~80CV。The separation and purification method according to any one of claims 1 to 8, wherein in step 2), the elution amount of the eluent is 60 to 80 CV.
  10. 根据权利要求1-9之一所述的分离纯化方法,其特征在于,所述分离纯化方法包括如下步骤:The separation and purification method according to any one of claims 1 to 9, wherein the separation and purification method comprises the following steps:
    1)上样:将纯度为64~66%的尿苷三磷酸粗品过滤后上样到层析柱中,其中,所述层析柱的装柱体积为4~20mL,上样载量为10~30g/L,所述层析柱填料是基质为聚丙烯酸酯的单分散微球UniQ-50XS;1) Sample loading: The crude uridine triphosphate with a purity of 64-66% is filtered and loaded onto a chromatography column, wherein the column packing volume of the chromatography column is 4-20 mL, and the sample loading capacity is 10 ~ 30g / L, the chromatography column packing is a monodisperse microsphere UniQ-50XS whose matrix is polyacrylate;
    2)洗脱:对吸附在层析柱中的UTP用洗脱液进行洗脱,其中,所述洗脱液含0.5~2mol的盐溶液,且不含有机溶剂,所述洗脱液的流速为200~300cm/h,所述洗脱液的洗脱量为60~80CV;2) Elution: The UTP adsorbed in the chromatography column is eluted with an eluent, wherein the eluent contains 0.5 to 2 mol of salt solution and contains no organic solvent, and the flow rate of the eluent 200-300cm / h, the elution amount of the eluent is 60-80CV;
    3)收集汇总:对洗脱后的尿苷三磷酸溶液进行分段收集,对符合目的峰值要求的组份液进行汇总。3) Collection and collection: The eluted uridine triphosphate solution is collected in stages, and the component liquids that meet the target peak requirements are collected.
PCT/CN2019/120049 2018-11-22 2019-11-21 Separation and purification method for uridine triphosphate WO2020103916A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811401447.4A CN109503687B (en) 2018-11-22 2018-11-22 Separation and purification method of uridine triphosphate
CN201811401447.4 2018-11-22

Publications (1)

Publication Number Publication Date
WO2020103916A1 true WO2020103916A1 (en) 2020-05-28

Family

ID=65749607

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/120049 WO2020103916A1 (en) 2018-11-22 2019-11-21 Separation and purification method for uridine triphosphate

Country Status (2)

Country Link
CN (1) CN109503687B (en)
WO (1) WO2020103916A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109503687B (en) * 2018-11-22 2022-03-08 苏州纳微科技股份有限公司 Separation and purification method of uridine triphosphate
CN114736260A (en) * 2022-03-29 2022-07-12 上海吉量医药工程有限公司 Preparation method of nucleotide triphosphate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509128A (en) * 1967-03-24 1970-04-28 Kyowa Hakko Kogyo Kk Process for purifying uridine-5'-diphosphate and uridine-5'-triphosphate
CN107868120A (en) * 2017-12-22 2018-04-03 苏州纳微科技有限公司 A kind of purification process of Daptomycin
CN109503687A (en) * 2018-11-22 2019-03-22 苏州纳微科技股份有限公司 A kind of isolation and purification method of uridine triphosphate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509128A (en) * 1967-03-24 1970-04-28 Kyowa Hakko Kogyo Kk Process for purifying uridine-5'-diphosphate and uridine-5'-triphosphate
CN107868120A (en) * 2017-12-22 2018-04-03 苏州纳微科技有限公司 A kind of purification process of Daptomycin
CN109503687A (en) * 2018-11-22 2019-03-22 苏州纳微科技股份有限公司 A kind of isolation and purification method of uridine triphosphate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RUAN, WENHUI ET AL.: "Thermodynamics and Kinetics of the Adsorption of UTP onto the DuoliteA-30 Resin", ION EXCHANGE AND ADSORPTION, no. 4, 20 August 2008 (2008-08-20) *

Also Published As

Publication number Publication date
CN109503687B (en) 2022-03-08
CN109503687A (en) 2019-03-22

Similar Documents

Publication Publication Date Title
US10214552B2 (en) Method for purifying beta-nicotinamide mononucleotide
WO2020103916A1 (en) Separation and purification method for uridine triphosphate
US20160340378A1 (en) Method for purifying oxidized form of beta-nicotinamide adenine dinucleotide phosphate
CN103130876B (en) Preparing method of high-purity polymyxin B
CN103304613B (en) A kind of method of separation and purification 4 kinds of ucleosides chemical compositions from Snakegourd Peel
CN105001309B (en) A kind of isolation and purification method of Dalbavancin
CN107827943B (en) Method for extracting cytosine nucleoside from fermentation liquor
CN107033113B (en) Preparation method of high-purity quercetin
CN103242402B (en) The highly purified N of a kind of preparation fast 6the method of-(2-hydroxyethyl) adenosine
CN109942663B (en) Method for preparing cycloastragenol by using diphasic acid hydrolysis
WO2020147421A1 (en) Sugammadex isolation and purification method
CN104892686B (en) A kind of isolation and purification method of Armillaria luteo-virens fructification nucleoside compound
CN101580528B (en) Method for purifying cytidine (deoxidation) and derivatives thereof
CN113278039A (en) Method for efficiently and continuously purifying beta-nicotinamide mononucleotide
CN101906091B (en) Method for preparing and separating tectorigenin from iris in high-speed countercurrent chromatography by one step
CN104483419A (en) Detection method of bortezomib intermediate
CN104231057B (en) The purification process of the copper chelate of bleomycin A5 and its congeners
CN101475621B (en) Method for purifying clofarabine by using chromatographic column
CN111735899B (en) Analysis method of naphthalene ring containing substituent
WO2022110003A1 (en) Purification method for pneumocandin b0
CN102399247B (en) Method for separating potassium myronate compounds from indigowoad root
CN107353299B (en) A kind of preparation method and applications of pteridine folic acid
CN1711908A (en) Production of high-purity capsaicin crystal by ion exchange resin method
CN103065753A (en) Magnetic nano-particle and preparation method thereof
CN102796088B (en) Method for preparing lamivudine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19888218

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19888218

Country of ref document: EP

Kind code of ref document: A1